The battle for intellectual property is building up with the companies in the sequencing business. A few months ago Illumina filed a legal suit. How 
this will all work out will be interesting to see. I just posted today about another newcomer that intends to drive pricing even down lower, an interesting foreground by all means. BD
Gene Sequencing Companies in Court -Illumina Files Patent Infringement Suit Against Affymetrix
In what is shaping up as the battle of San Diego’s biotechnology tools titans, Life Technologies (NASDAQ: LIFE) has filed a patent-infringement suit against rival Illumina, claiming that some of Illumina’s best-selling genetic-sequencing products violate Life Tech’s intellectual property.
The suit, filed in U.S. District Court in Delaware, claims that certain Illumina products, including the Genome Analyzer and the second-generation Genome Analyzer II, infringe upon three Life Tech patents. The suit seeks an unspecified amount in damages, and a permanent injunction restraining Illumina (NASDAQ: ILMN) from further infringement. If granted, the injunction would prevent Illumina from selling its equipment.
Life Tech and Illumina, Two San Diego Biotech Giants, in Patent Dispute | Xconomy
Related Reading:
Gene Sequencing Companies in Court -Illumina Files Patent ...
Geospiza Cuts Deal With Illumina, To Help Scientists Cope With ...
CLC Joins Illumina Bioinformatics Partnering Program – Sequencing ...
0 comments :
Post a Comment